Key facts
- This page summarizes Jeannine Sheehan's Form 4 filing for InfuSystem Holdings, Inc (INFU).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 17 May 2022, 17:13.
Jeannine Sheehan - 17 May 2022 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)
- Reporting relationship
- Chief Administrative Officer
- Issuer ticker
- INFU
- Reported as of
- 17 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 May 2022, 17:13:20 UTC
- Prior SEC filing
- 04 Jan 2022
- Next SEC filing
- 20 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin Whitman, Attorney-in-Fact for Jeannine Sheehan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeannine Sheehan filed Form 4 for InfuSystem Holdings, Inc (INFU) on 17 May 2022.
Change
- Previous filing in this sequence was filed on 04 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INFU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 19,152
- Date
- 17 May 2022
- Ownership
- Direct
- Footnotes
- F1
INFU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 345
- Date
- 17 May 2022
- Ownership
- By children
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INFU
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +18,995
- Change %
- Price
- $0.000000
- Shares after
- 18,995
- Date
- 17 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,995
- Exercise price
- $8.58
- Footnotes
- F3, F4
INFU
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +12,955
- Change %
- Price
- $0.000000
- Shares after
- 12,955
- Date
- 17 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,955
- Exercise price
- Footnotes
- F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
This total includes an additional 1,545 shares acquired recently through the Company's Employee Stock Purchase Plan
Footnote F2
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Footnote F3
The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.
Footnote F4
The option, representing the right to purchase a total of 18,995 shares of InfuSystem Holdings, Inc. common stock, vests in three equal annual installments beginning May 17, 2023.
Footnote F5
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F6
These restricted stock units will cliff vest on May 17, 2025.